Página Nct de ensaios clínicos
Clinical Trial Results:
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase III Study of Rosuvastatin (CRESTOR) 20 mg in the Primary Prevention of Cardiovascular Events Among Subjects with Low Levels of LDL Cholesterol and Elevated Levels of C-Reactive Protein
| Summary | |
EudraCT number | 2004-004094-28 |
Trial protocol | NO DE GB EE DK |
Global completion date | 20 Aug 2008 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 09 Oct 2016 |
First version publication date | 09 Oct 2016 |
Other versions | |
Summary report(s) | Clinical Study Report Synopsis D3560L00030 (4522US/0011) |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.